HIGHLIGHTS
- who: Lucy B. Cook from the (UNIVERSITY) have published the Article: Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies, in the Journal: (JOURNAL) of 29/04/2022
- what: By comparison with healthy controls, the authors report suboptimal responses following two primary vaccines, with significantly enhanced responses following the third primary dose. The MARCH study was designed to report real-world serological responses to SARS-CoV-2 vaccination in a large number of patients with haematological malignancies. There are of course biases in the nature of this study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.